CoChat

A bespoke health risk assessment methodology for the radiation protection of astronauts

Open access

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

An alternative approach that is particularly suitable for the radiation health risk assessment (HRA) of astronauts is presented. The quantity, Radiation Attributed Decrease of Survival (RADS), representing the cumulative decrease in the unknown survival curve at a certain attained age, due to the radiation exposure at an earlier age, forms the basis for this alternative approach. Results are provided for all solid cancer plus leukemia incidence RADS from estimated doses from theoretical radiation exposures accumulated during long-term missions to the Moon or Mars. For example, it is shown that a 1000-day Mars exploration mission with a hypothetical mission effective dose of 1.07 Sv at typical astronaut ages around 40 years old, will result in the probability of surviving free of all types of solid cancer and leukemia until retirement age (65 years) being reduced by 4.2% (95% CI 3.2; 5.3) for males and 5.8% (95% CI 4.8; 7.0) for females. RADS dose–responses are given, for the outcomes for incidence of all solid cancer, leukemia, lung and female breast cancer. Results showing how RADS varies with age at exposure, attained age and other factors are also presented. The advantages of this alternative approach, over currently applied methodologies for the long-term radiation protection of astronauts after mission exposures, are presented with example calculations applicable to European astronaut occupational HRA. Some tentative suggestions for new types of occupational risk limits for space missions are given while acknowledging that the setting of astronaut radiation-related risk limits will ultimately be decided by the Space Agencies. Suggestions are provided for further work which builds on and extends this new HRA approach, e.g., by eventually including non-cancer effects and detailed space dosimetry.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00411-021-00910-0

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Comparison of REIC and RADS, in decimals, for males for all solid cancer plus leukemia using age at exposure of 40, an attained age of 65, an organ dose of 1 Gy and equal weighting for the ERR and EAR in all solid cancer model and in the leukemia model. It is assumed here that the effective dose, E in Sv is equal to the organ dose in Gy. Note: the very large uncertainties in the survival curve from e.g., the radiation dependant acute mortality in the survival curves above 2 Gy, are not included in the results for REIC
Fig. 1 Comparison of REIC and RADS, in decimals, for males for all solid cancer plus leukemia using age at exposure of 40, an attained age of 65, an organ dose of 1 Gy and equal weighting for the ERR and EAR in all solid cancer model and in the leukemia model. It is assumed here that the effective dose, E in Sv is equal to the organ dose in Gy. Note: the very large uncertainties in the survival curve from e.g., the radiation dependant acute mortality in the survival curves above 2 Gy, are not included in the results for REICCC BY · PubMed Central
Fig. 2 Comparison of REIC and RADS, in decimals, for females for all solid cancer plus leukemia using age at exposure of 40, an attained age of 65, an organ dose of 1 Gy and equal weighting for the ERR and EAR all solid cancer model and leukemia model. It is assumed here that the effective dose, E in Sv is equal to the organ dose in Gy. Note: the very large uncertainties in the survival curve from e.g., the radiation dependant acute mortality in the survival curves above 2 Gy, are not included in the results for REIC
Fig. 2 Comparison of REIC and RADS, in decimals, for females for all solid cancer plus leukemia using age at exposure of 40, an attained age of 65, an organ dose of 1 Gy and equal weighting for the ERR and EAR all solid cancer model and leukemia model. It is assumed here that the effective dose, E in Sv is equal to the organ dose in Gy. Note: the very large uncertainties in the survival curve from e.g., the radiation dependant acute mortality in the survival curves above 2 Gy, are not included in the results for REICCC BY · PubMed Central
Fig. 3 RADS incidence risks for men, in decimals, for different cancer groupings, calculated for an age at exposure of 40 years, an attained age of 65 years and a dose of 1 Gy using a mixed ERR and EAR model. The weights, w, for the mixed ERR and EAR (ERR: EAR) are: all solid cancer, abbreviated to solid cancer in the graphics (0.5: 0.5), leukemia (0.5: 0.5), lung and lung adjusted for non-smoking (0.3: 0.7)
Fig. 3 RADS incidence risks for men, in decimals, for different cancer groupings, calculated for an age at exposure of 40 years, an attained age of 65 years and a dose of 1 Gy using a mixed ERR and EAR model. The weights, w, for the mixed ERR and EAR (ERR: EAR) are: all solid cancer, abbreviated to solid cancer in the graphics (0.5: 0.5), leukemia (0.5: 0.5), lung and lung adjusted for non-smoking (0.3: 0.7)CC BY · PubMed Central
Fig. 4 RADS incidence risks for women, in decimals, for different cancer groupings, calculated for an age at exposure of 40 years, an attained age of 65 years and a dose of 1 Gy using a mixed ERR and EAR model. The weights, w, for the mixed ERR and EAR are: (ERR: EAR) all solid cancer, abbreviated to solid cancer in the graphics (0.5: 0.5), leukemia (0.5: 0.5), lung and lung adjusted for non-smoking (0.3: 0.7), breast (0: 1)
Fig. 4 RADS incidence risks for women, in decimals, for different cancer groupings, calculated for an age at exposure of 40 years, an attained age of 65 years and a dose of 1 Gy using a mixed ERR and EAR model. The weights, w, for the mixed ERR and EAR are: (ERR: EAR) all solid cancer, abbreviated to solid cancer in the graphics (0.5: 0.5), leukemia (0.5: 0.5), lung and lung adjusted for non-smoking (0.3: 0.7), breast (0: 1)CC BY · PubMed Central
Fig. 5 European CI5–8 country lung cancer age-specific incidence data (rates are in units of number of incident cases per 100,000 persons, in one year). The top panel shows the actual CI5–8 country data and the lower panel shows how these rates change after adjustment to non-smoking rates using the method described
Fig. 5 European CI5–8 country lung cancer age-specific incidence data (rates are in units of number of incident cases per 100,000 persons, in one year). The top panel shows the actual CI5–8 country data and the lower panel shows how these rates change after adjustment to non-smoking rates using the method describedCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. Preston DL, Lubin JH, Pierce DA (1993) Epicure user’s guide. HiroSoft International Corp., Seattle

Cited by

See all 25

Metadata

Authors
Walsh, L., Hafner, L., Straube, U., Ulanowski, A., Fogtman, A., Durante, M., Weerts, G., & Schneider, U.
Affiliations
  • University of Zurich (CH)
  • ETH Zurich (CH)
  • European Space Agency (FR)
  • International Atomic Energy Agency (AT)
  • GSI Helmholtz Centre for Heavy Ion Research (DE)
Corresponding author
Walsh, Linda
Venue
Radiation and Environmental Biophysics
Published
2021-04-30
Volume
60
Issue
2
Pages
213-231
ISSN
  • 0301-634X (ISSN-L)
  • 1432-2099
OpenAlex
W3159629405
Cited by
23
References
44
Citations by year
2026: 2 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 1
FWCI
2.51
Type
journal article
Language
en
Open access
Licence
Locations
  • Radiation and Environmental Biophysics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion, cc-by)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
  • Site cant be reached (submittedVersion, cc-by)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • ETH Zürich Research Collection (cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • European Space Agency
  • Universität Zürich
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiation Dose and Imaging
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
Keywords
astronaut radiation protection, health risk assessment, leukemia incidence, long-duration spaceflight, Mars exploration, lunar missions, dose-response relationship, age at exposure, survival probability, space dosimetry
MeSH terms
Radiation Exposure, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Models, Theoretical, Neoplasms, Radiation-Induced, Occupational Diseases, Radiation Protection, Space Flight, Occupational Exposure, Astronauts, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A bespoke health risk assessment methodology for the radiation protection of astronauts. https://app.cochat.ai/papers/10.1007/s00411-021-00910-0
The paper
Walsh, L., Hafner, L., Straube, U., Ulanowski, A., Fogtman, A., Durante, M., Weerts, G., & Schneider, U. (2021). A bespoke health risk assessment methodology for the radiation protection of astronauts. Radiation and Environmental Biophysics. https://doi.org/10.1007/s00411-021-00910-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.